Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hangzhou Biotest Biotech CoSHSE:688767 -1.20%67 5-Year Yield-on-Cost % is 1.66 as of Aug. 18, 2026, which is 50% below its 10-year median of 3.33. GuruFocus rates SHSE:688767 with a GF Score™ of 67/100 and a GF Value™ of ¥27.96 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 149 Biotechnology companies, Hangzhou Biotest Biotech Co ranks better than 50.34% on this metric.
The historical rank and industry rank for Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688767'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.65 Med: 3.33 Max: 10.81
Current: 1.66
During the past 9 years, Hangzhou Biotest Biotech Co's highest Yield on Cost was 10.81. The lowest was 1.65. And the median was 3.33.
SHSE:688767's 5-Year Yield-on-Cost % is ranked better than 50.34% of 149
companies
in the Biotechnology industry
Industry Median: 1.64
vs SHSE:688767: 1.66
Hangzhou Biotest Biotech Co (SHSE:688767) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Hangzhou Biotest Biotech Co 5-Year Yield-on-Cost % Related Terms
SHSE:688767 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Biotest Biotech Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost % falls into.
Hangzhou Biotest Biotech Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Hangzhou Biotest Biotech Co (SHSE:688767) has a 5-Year Yield-on-Cost % of 1.66 as of Aug. 18, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hangzhou Biotest Biotech Co and its competitors. This is 50% below median its historical median of 3.33. Over the past decade, Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost % has ranged from 1.65 to 10.81. According to the industry distribution chart, Hangzhou Biotest Biotech Co ranks #74 out of 149 companies in the Biotechnology industry, placing it in the top 49.7%.
Is Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost % too high?
Hangzhou Biotest Biotech Co's current 5-Year Yield-on-Cost % of 1.66 is 50% below median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 1.65 to a high of 10.81. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.64. Hangzhou Biotest Biotech Co's value of 1.66 is 1.2% above this industry median. Based on the distribution chart, Hangzhou Biotest Biotech Co ranks #74 out of 149 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Hangzhou Biotest Biotech Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Biotest Biotech Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hangzhou Biotest Biotech Co ranks #74 out of 149 companies for 5-Year Yield-on-Cost %. This puts Hangzhou Biotest Biotech Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 1.64. Hangzhou Biotest Biotech Co's value of 1.66 is 1.2% above this benchmark. Historically, Hangzhou Biotest Biotech Co's own 5-Year Yield-on-Cost % has ranged from 1.65 to 10.81 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 1.64, Hangzhou Biotest Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.64, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Biotest Biotech Co's current 5-Year Yield-on-Cost % of 1.66 is 1.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hangzhou Biotest Biotech Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Biotest Biotech Co's current 5-Year Yield-on-Cost % is 1.66, which is 50% below median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Biotest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co (SHSE:688767) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥27.96, compared to a current price of ¥41.84 — trading 49.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.66, which is 50% below median its 10-year median of 3.33 and 1.2% above the Biotechnology industry median of 1.64. Hangzhou Biotest Biotech Co's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Hangzhou Biotest Biotech Co (SHSE:688767), the current 5-Year Yield-on-Cost % is 1.66 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Biotest Biotech Co (SHSE:688767) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co stock appears to be overvalued.
The current stock price of ¥41.84 is trading 49.6% above its estimated GF Value™ of ¥27.96.
GuruFocus considers Hangzhou Biotest Biotech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688767:
5-Year Yield-on-Cost %: 1.66 (50% below median its 10-year median of 3.33)
GF Value™: ¥27.96 vs. price of ¥41.84 (49.6% above fair value)
Industry Position: 1.2% above the Biotechnology median (#74 of 149)
No single metric tells the full story. See the SHSE:688767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
67GF Score
Get the complete analysis for SHSE:688767
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688767 has been successfully added to your 
